Pharma Focus America
ThermoFisherScientific - Custom and Bulks

LATEST NEWSRead more...

19

Jun 2024

Marea Therapeutics Begins Operations with $190 Million to Advance Innovative Cardiometabolic Disease Therapies

Marea Therapeutics a biotechnology company launched by Third Rock Ventures announced today that it has secured million in combined Series A and B financings The Series A round was led by Third Rock

19

Jun 2024

Italfarmaco Partners with Iktos to Advance Drug Discovery Through Artificial Intelligence

Italfarmaco SpA a global pharmaceutical leader and Iktos a company specializing in artificial intelligence for drug development have formed a partnership to create nextgeneration HDAC inhibitors

19

Jun 2024

Thermo Fisher Scientific Expands Its Clinical Research Facility in Wisconsin

Thermo Fisher Scientific Inc a leader in scientific services worldwide has launched a new clinical research laboratory at its GMP facility in Middleton Wisconsin This expansion spanning square feet is intended to bolster the sites capabilities in chemistry manufacturing and control analytics aimed...

19

Jun 2024

Belharra Therapeutics Forms Alliance with Sanofi to Develop Novel Treatments for Immune System Disorders

Belharra Therapeutics a company specializing in chemoproteomics for small molecule drug discovery has announced a strategic collaboration with Sanofi aimed at developing new small molecule therapies

18

Jun 2024

Gyros Protein Technologies Launches Gyrolab Generic Anti-AAV Kit to Propel Gene Therapy Innovation

Gyros Protein Technologies AB known for its pioneering work in automated nanoliterscale immunoassays and peptide synthesizers has introduced the Gyrolab Generic AntiAdeno Associated Virus

17

Jun 2024

Adalvo Receives Initial EU Approval for Generic Liraglutide Prefilled Pen

Adalvo has announced the successful approval of the liraglutide prefilled pen under the EUs DCP marking a milestone as the first generic drug approval in the region According to IQVIA reports this peptide drug a bioequivalent of the Victoza prefilled pen and used for treating type diabetes achieved...

press releasesRead more...

KalVista Submits New Drug Application to FDA for Sebetralstat as First Oral On-demand Treatment for Hereditary Angioedema

KalVista Pharmaceuticals Inc today announced the submission of a New Drug Application for US Food and Drug Administration review of sebetralstat a novel investigational oral plasma

AbTherx Opens Antibody Discovery Technologies Research Center

AbTherx Inc a biotechnology company with innovative technologies that enable and accelerate antibody discovery today announced the opening of its new antibody discovery technologies research center

Aprea Therapeutics Announces First Patient Dosed in ACESOT-1051 Phase 1 Trial Evaluating Oral WEE1 Inhibitor APR-1051

Aprea Therapeutics Inc a clinicalstage biopharmaceutical company focused on precision oncology through synthetic lethality today announced that the first patient has been dosed in the ACESOT Phase study evaluating

U.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults

Merck known as MSD outside of the United States and Canada announced today that the US Food and Drug Administration has approved CAPVAXIVE

18 - 20

Jun 2024

18 - 20

Jun 2024

19 - 21

Jun 2024

CPHI & PMEC China 2024

Shanghai, China

20 - 22

Jun 2024

VACCINESFORUM2024

Porto, Portugal

25 - 27

Jun 2024

Future Pharma

Boston, MA, USA

25 - 26

Jun 2024

25 - 27

Jun 2024
Testing The WorldCelebrating 70 Years of Nalgene
Thermo Fisher Scientific viral vector services (VVS)
Future Labs Live USA 2024
patheon - Mastering API production at every scale
World Orphan Drug Congress Europe 2024

TOP ARTICLES

  • 2

    Challenges and Opportunities in Market Access for New Drugs

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 3

    The Critical Role of Contract Research Organizations in Pharma Development

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 4

    Understanding Over-the-Counter (OTC) Drugs: Trends and Opportunities in Pharma

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

  • 5

    Navigating the Storm: Emerging Challenges in the Pharmaceutical Industry

    Kate Williamson

    Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

KNOWLEDGE BANK

EDITORIAL SECTION

  • Information Technology

    How AI is Transforming the Pharma Industry

    The global pharmaceutical industry is currently facing many wide ranging challenges including an aging population increased life expectancy a rise in chronic conditions reduced funding for treatments reduced numbers of clinical staff the ever increasing cost of drug development and raw materials and supply chain issues